Kikuno Murayama-Oda
Research Subjects
Research Interests
Kikuno Murayama-Oda has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Hee-Kyoung Kim
Department of Nutrition and Physiological Chemistry, Osaka University Medical School 2–2 Yamadaoka, Suita, Osaka 565
3 shared publicationsKiichi Imamura
Department of Nutrition and Physiological Chemistry, Osaka University Medical School
3 shared publications- Norihide Murayama
MURAYAMA Pediatrics, 3-2-33 Nagayoshi-Nagahara-Higashi, Hirano-ku, Osaka-shi, Osaka 547-0013, Japan
3 shared publications Takehiko Tanaka
Department of Nutrition and Physiological Chemistry, Osaka University Medical School 2–2 Yamadaoka, Suita, Osaka 565
2 shared publicationsTakao Tsuji
Department of Nutrition and Physiological Chemistry, Osaka University Medical School, 2‐2 Yamadaoka, Suita‐shi, Osaka 565
1 shared publicationTakehiko Takehiko
Department of Nutrition and Physiological Chemistry, Osaka University Medical School, Nakanoshima, Kita‐ku, Osaka 530
1 shared publication
Latest Publications
- Open Access
- 1 October 2018
- Published by Elsevier in Data in Brief
- Vol. 20, 1580-1586
Data on substantial gravity of carbon dioxide due to pressured metered-dose inhaler steroid treatments for the 2006 year in Japan
- 1 October 2018
- Published by Elsevier in Data in Brief
- Vol. 20, 1580-1586
Open AccessData on substantial gravity of carbon dioxide due to pressured metered-dose inhaler steroid treatments for the 2006 year in Japan
- Open Access
- 1 October 2018
- Published by Elsevier in Data in Brief
- Vol. 20, 1573-1579
Data on nasal eosinophil positive rates in childhood asthma on each age
- 1 October 2018
- Published by Elsevier in Data in Brief
- Vol. 20, 1573-1579
Open AccessData on nasal eosinophil positive rates in childhood asthma on each age
- Open Access
- 1 June 2018
- Published by Elsevier in Data in Brief
- Vol. 18, 1895-1899
Data on various allergen specific IgEs and prospective treatments on food-dependent exercise-induced anaphylaxis
- 1 June 2018
- Published by Elsevier in Data in Brief
- Vol. 18, 1895-1899
Open AccessData on various allergen specific IgEs and prospective treatments on food-dependent exercise-induced anaphylaxis
- 1 April 1991
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 109 (4) , 507-513
Metabolic Deviation of Mouse Liver by RhILl-α or RhTNF/Cachectin1
In this work deviation of liver metabolism by cytokines, especially recombinant human interleukin 1-α (rhILl-α), was investigated. Administration of rhILl-α or recombinant human tumor necrosis factor (rhTNF/cachectin) to normal mice resulted in rapid, dose-dependent induction of high liver ornithine decarboxylase (ODC) activity. The effects of these cytokines on liver ODC were not indirect effects mediated by eicosanoids. The induction of liver ODC by rhILl-α was at least partly a direct effect on hepatocytes, and was due to increase in de novo synthesis of the enzyme protein after increase in ODC mRNA. No specific protein was required for increase in the level of ODC-mRNA. On ILl treatment, actinomycin D caused superinduction of liver ODC, which was at least partly due to increased stability of the ODC enzyme, because actinomycin D doubled the apparent half-life (from 50 to 95 min). Daily administration of 2×103 U of rhILl-α to mice for 3 days also caused decrease in the level of the differentiated type of pyruvate kinase isozyme (PK-L) and marked increase in that of the prototype isozyme (PK-M2) in the liver, but did not cause significant change in the isozyme patterns of the kidney, thymus, and spleen. RhILl-α also induced hypertrophy of the spleen. These results indicate that rhILl-α causes metabolic deviation of the liver similar to that in tumor-bearing hosts.
- 1 April 1991
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 109 (4) , 507-513
Metabolic Deviation of Mouse Liver by RhILl-α or RhTNF/Cachectin1
In this work deviation of liver metabolism by cytokines, especially recombinant human interleukin 1-α (rhILl-α), was investigated. Administration of rhILl-α or recombinant human tumor necrosis factor (rhTNF/cachectin) to normal mice resulted in rapid, dose-dependent induction of high liver ornithine decarboxylase (ODC) activity. The effects of these cytokines on liver ODC were not indirect effects mediated by eicosanoids. The induction of liver ODC by rhILl-α was at least partly a direct effect on hepatocytes, and was due to increase in de novo synthesis of the enzyme protein after increase in ODC mRNA. No specific protein was required for increase in the level of ODC-mRNA. On ILl treatment, actinomycin D caused superinduction of liver ODC, which was at least partly due to increased stability of the ODC enzyme, because actinomycin D doubled the apparent half-life (from 50 to 95 min). Daily administration of 2×103 U of rhILl-α to mice for 3 days also caused decrease in the level of the differentiated type of pyruvate kinase isozyme (PK-L) and marked increase in that of the prototype isozyme (PK-M2) in the liver, but did not cause significant change in the isozyme patterns of the kidney, thymus, and spleen. RhILl-α also induced hypertrophy of the spleen. These results indicate that rhILl-α causes metabolic deviation of the liver similar to that in tumor-bearing hosts.
- 1 March 1991
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 82 (3) , 315-324
Purification of Ornithine Decarboxylase-inducing Factor from Cell-free Ascites Fluid of Ehrlich Ascites Tumor and Its Characteristics
The ornithine decarboxylase-inducing factor (ODC factor) was purified about 1,000-fold in 42% yield from the ascites fluids of an Ehrlich ascites tumor by a combination of centrifugation and concanavalin A (ConA) treatment. A single ip injection of 0.5 micrograms of the purified factor per mouse resulted in half-maximum induction of liver ODC. The factor was found to be a trypsin- and chymotrypsin-resistant, acidic glycoprotein (pI about 4.43) with a minimum molecular weight of about 70 kilodaltons, containing a disulfide bond(s) in its functional domain. It did not react with ConA. This factor induced retrodifferentiation of liver function, causing a marked increase of prototype M2 isozyme of pyruvate kinase. It reduced liver catalase activity, and also modified thyroid hormone metabolism, reducing the serum levels of T4 and T3. These results suggest that the ODC factor is multifunctional and induces many of the changes observed in a tumor-bearing host.
- 1 March 1991
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 82 (3) , 315-324
Purification of Ornithine Decarboxylase-inducing Factor from Cell-free Ascites Fluid of Ehrlich Ascites Tumor and Its Characteristics
The ornithine decarboxylase-inducing factor (ODC factor) was purified about 1,000-fold in 42% yield from the ascites fluids of an Ehrlich ascites tumor by a combination of centrifugation and concanavalin A (ConA) treatment. A single ip injection of 0.5 micrograms of the purified factor per mouse resulted in half-maximum induction of liver ODC. The factor was found to be a trypsin- and chymotrypsin-resistant, acidic glycoprotein (pI about 4.43) with a minimum molecular weight of about 70 kilodaltons, containing a disulfide bond(s) in its functional domain. It did not react with ConA. This factor induced retrodifferentiation of liver function, causing a marked increase of prototype M2 isozyme of pyruvate kinase. It reduced liver catalase activity, and also modified thyroid hormone metabolism, reducing the serum levels of T4 and T3. These results suggest that the ODC factor is multifunctional and induces many of the changes observed in a tumor-bearing host.
- 1 January 1991
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 82 (1) , 98-108
Mechanism of Metabolic Abnormality of Thyroid Hormones in Walker 256 Carcinosarcoma-bearing Rats
We examined the mechanism of abnormality of thyroid hormone metabolism in Walker 256 carcino‐sarcoma‐bearing rats. The serum levels of thyroxine (T4), 3,5,3′‐triiodothyronine (T3) and thyroid‐stimulating hormone (TSH), and the responses of serum T4 and T3 to exogenous TSH in tumor‐bearing rats on day 14 after inoculation of tumor cells were significantly less than those in pair‐fed control (PFC) rats, suggesting that the metabolic abnormality of thyroid hormones may be caused by disorder of both peripheral and central functions, and that a certain tumor‐derived factor may be involved in this abnormality. An active factor responsible for the metabolic abnormality was found in soluble cytosol fraction (SF) of the tumor cells. Administration of the SF to normal rats significantly reduced their serum T4 and T3 concentrations, liver 5 ‐deiodinase (5′‐DI) activity, responsiveness of the thyroid gland to TSH and food intake compared with those of PFC rats, but, unlike the tumor, did not reduce the serum TSH level. This biologically active factor in the SF was found to be a heat‐labile protein and specific to the tumor. It was tentatively named serum thyroid hormone reducing factor (STRF). STRF was partially purified from the SF by ammonium sulfate fractionation and DEAE‐cellulose chromatography. Partially purified STRF preparation significantly diminished the serum T4 and T3 concentrations and liver S′‐DI activity and food intake of normal rats compared with those of PFC rats, mimicking the changes associated with the tumor in tumor‐bearing animals. These results suggested that abnormality of thyroid hormone metabolism in tumor‐bearing animals may partly be caused by STRF‐mediated modulation at peripheral and thyroid gland levels. Whether STRF actually induces anorexia remains to he clarified.
- 1 January 1991
- Published by Wiley in Japanese Journal of Cancer Research
- Vol. 82 (1) , 98-108
Mechanism of Metabolic Abnormality of Thyroid Hormones in Walker 256 Carcinosarcoma-bearing Rats
We examined the mechanism of abnormality of thyroid hormone metabolism in Walker 256 carcino‐sarcoma‐bearing rats. The serum levels of thyroxine (T4), 3,5,3′‐triiodothyronine (T3) and thyroid‐stimulating hormone (TSH), and the responses of serum T4 and T3 to exogenous TSH in tumor‐bearing rats on day 14 after inoculation of tumor cells were significantly less than those in pair‐fed control (PFC) rats, suggesting that the metabolic abnormality of thyroid hormones may be caused by disorder of both peripheral and central functions, and that a certain tumor‐derived factor may be involved in this abnormality. An active factor responsible for the metabolic abnormality was found in soluble cytosol fraction (SF) of the tumor cells. Administration of the SF to normal rats significantly reduced their serum T4 and T3 concentrations, liver 5 ‐deiodinase (5′‐DI) activity, responsiveness of the thyroid gland to TSH and food intake compared with those of PFC rats, but, unlike the tumor, did not reduce the serum TSH level. This biologically active factor in the SF was found to be a heat‐labile protein and specific to the tumor. It was tentatively named serum thyroid hormone reducing factor (STRF). STRF was partially purified from the SF by ammonium sulfate fractionation and DEAE‐cellulose chromatography. Partially purified STRF preparation significantly diminished the serum T4 and T3 concentrations and liver S′‐DI activity and food intake of normal rats compared with those of PFC rats, mimicking the changes associated with the tumor in tumor‐bearing animals. These results suggested that abnormality of thyroid hormone metabolism in tumor‐bearing animals may partly be caused by STRF‐mediated modulation at peripheral and thyroid gland levels. Whether STRF actually induces anorexia remains to he clarified.